MEDICAL TECHNOLOGY SYSTEMS INC /DE/
8-K, 2000-01-18
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: GOLDMAN SACHS TRUST, NSAR-A/A, 2000-01-18
Next: MPHASE TECHNOLOGIES INC, 10KSB40, 2000-01-18






                                       1
<PAGE>


                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

         Date of Report (Date of earliest event reported): January 14, 2000

                        MEDICAL TECHNOLOGY SYSTEMS, INC.
                        --------------------------------
             (Exact name of registrant as specified in its charter)


          Delaware                      0-16594                   59-2740462
- ----------------------------    ------------------------    --------------------
(State or other jurisdiction    (Commission File Number)       (IRS Employer
     of incorporation)                                       Identification No.)


              12920 Automobile Boulevard, Clearwater, Florida 37622
              -----------------------------------------------------
               (Address of principal executive offices) (Zip Code)


Registrant's telephone number, including area code:     (727) 576-6311
                                                       ---------------

                                       N/A
         -------------------------------------------------------------
         (Former name or former address, if changed since last report)



                                       2
<PAGE>


     This  document  and  the  accompanying   exhibit  contain  statements  that
constitute "forward-looking statements" within the meaning of Section 27A of the
Securities  Act of 1933,  as  amended,  and Section  21E of the  Securities  and
Exchange Act of 1934, as amended.  The words  "believe",  "estimate",  "expect",
"intend",  "anticipate" and similar  expressions and variations thereof identify
certain of such forward-looking statements,  which speak only as of the dates on
which they were made. The Company undertakes no obligation to publicly update or
revise any forward-looking  statements,  whether as a result of new information,
future events or otherwise.  Readers are cautioned that any such forward-looking
statements  are not  guarantees  of future  performance  and  involve  risks and
uncertainties,  and  that  actual  results  may  differ  materially  from  those
indicated  in the  forward-looking  statements  as a result of various  factors.
Readers  are  cautioned  not to place undue  reliance  on these  forward-looking
statements.


Item 2.   Acquisition or Disposition of Assets

     Medical Technology Systems, Inc. ("the Company") sold certain assets of its
wholly  owned  subsidiary,  Medical  Technology  Laboratories,  Inc.  ("MTL") to
Brittany Leigh,  Inc.  ("Brittany"),  an unrelated third party.  The assets were
comprised of goodwill,  laboratory  equipment,  computers,  office equipment and
certain accounts receivable.

     The assets were sold in consideration of One Million Dollars  ($1,000,000),
and the assumption of approximately  Four Hundred Thousand Dollars ($400,000) of
liabilities.  The sale consideration was determined through negotiations between
the parties.


Item 7.   Financial Statements, Pro-Forma Financial Information and Exhibits

          (a)      Exhibits.  See Index to Exhibits.


                                   SIGNATURES


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: January 18, 2000

                                  MEDICAL TECHNOLOGY SYSTEMS, INC.
                                  (Registrant)

                                  By: /s/ Michael P. Conroy
                                      ------------------------------------------
                                      Michael P. Conroy
                                      Vice President and Chief Financial Officer


                                       3
<PAGE>

                                  EXHIBIT INDEX


                        MEDICAL TECHNOLOGY SYSTEMS, INC.

                           Current Report on Form 8-K

                             Dated: January 18, 2000


        EXHIBIT NO.                               DESCRIPTION
- ----------------------------      ----------------------------------------------
           10.1                   Asset Purchase Agreement Dated January 1, 2000





                                       1
<PAGE>


                            ASSET PURCHASE AGREEMENT


         This  ASSET  PURCHASE  AGREEMENT  is dated as of  January  1, 2000 (the
"Agreement"),  and is between  Brittany Leigh,  Inc., or its assigns,  a Florida
corporation (the "Buyer"), and Medical Technology Laboratories,  Inc., a Florida
corporation (the "Seller").

                                   Background

     The  Seller  operates  a  Medicare  certified   clinical   laboratory  (the
"Purchased  Assets"  )  and  this  Agreement  contemplates  a  transaction  (the
"Acquisition") in which (i) the Seller will sell certain specified assets (which
shall include the Purchased Assets) of the Seller to the Buyer, Buyer will lease
back the purchased  assets (the  "Leaseback")  in accordance  with the terms and
conditions of this  Agreement.  The board of directors of the Seller and Medical
Technologies  Systems,  Inc. (the  "Shareholder"),  the sole  shareholder of the
Seller has approved this  Agreement and the  transactions  contemplated  by this
Agreement  and the  board of  directors  of the Buyer  has  determined  that the
Acquisition is in the best interests of the Buyer and its  shareholders  and has
approved and adopted this Agreement and the  transactions  contemplated  by this
Agreement.

     In connection with the  negotiation and preparation of this Agreement,  the
Seller and the Buyer have prepared a set of disclosure schedules, dated the date
hereof  and  delivered  separately  as  one or  more  volumes  (the  "Disclosure
Schedule",  with any  reference  in this  Agreement  to a Schedule  being to the
Disclosure Schedule).

     The parties  acknowledge  that all of the Purchased Assets are subject to a
first  priority  security  interest  in  favor  of  SouthTrust  Bank,   National
Association ("STB") and that the transactions contemplated by this Agreement are
subject to the consent of STB.

     Accordingly,  in  consideration  of the above and the mutual  covenants and
agreements set forth below, the Buyer and the Seller agree as follows:



                                       2
<PAGE>

                                      Terms

                                    ARTICLE I

                           Closing, Purchase and Sale

     SECTION 1.01. Closing.

     (a) Time and  Place.  The  closing  of the  transfer  and  delivery  of all
documents and instruments necessary to consummate the transactions  contemplated
by this Agreement (the "Closing") shall be held on or before January 1, 2000, or
on such other date and time as shall be mutually  agreed to by the Buyer and the
Seller,  at the offices of the Seller,  it being understood and agreed that time
is of the essence of this  Agreement.  The date on which the Closing is actually
held is  referred to as the  "Closing  Date".  The Closing  will be deemed to be
effective  for  purposes of this  Agreement as of the opening of business on the
Closing Date.  Unless otherwise  agreed by the parties,  the Closing shall occur
within the time period contemplated by Section 8.01(b), below.

     (b) Transactions at Closing. At the Closing:

          (i) The Seller shall duly execute and deliver to the Buyer such deeds,
     bills of sale, certificates of title and other instruments of assignment or
     transfer with respect to the Purchased  Assets, as the Buyer may reasonably
     request and as may be necessary to vest in the Buyer or its nominee(s) good
     record and marketable  title to all of the Purchased  Assets,  in each case
     subject to no encumbrance  (except as described in Schedule  1.01(b) and as
     otherwise  contemplated by this  Agreement).  The Seller shall also deliver
     the  proceeds of the sale to STB in exchange  for the release of STB of its
     liens on the Purchased Assets.

          (ii) The Buyer  shall pay the Cash  Price (as such term is  defined in
     Section  2.01 below) and shall duly  execute and deliver to the Seller such
     instruments,  as the  Seller may  reasonably  request,  including,  without
     limitation,   an  assignment  and  assumption  agreement  relating  to  the
     liabilities assumed by Buyer pursuant to this Agreement.

          (iii) The Seller  and Buyer  shall  execute a lease for the  Purchased
     Assets in  substantially  the form of Exhibit A (the "Lease").  Buyer shall
     assume the  obligations of Seller under the lease agreement dated September
     1, 1998 with James L. McKeown, Jr. (the "Real Property Lease").

     SECTION 1.02.  Purchased  Assets.  Subject to the terms and  conditions set
forth in this Agreement, at the Closing, the Seller shall sell, assign, transfer
and  deliver  to the  Buyer,  and the Buyer  shall  purchase,  acquire  and take
assignment  and  delivery  of, the  following  assets of the  Seller  used in or
relating to the business of Seller,  with the  exception of the Excluded  Assets
(as defined in Section 1.03,  with all of such assets  described in this Section
1.02 hereinafter referred to collectively as the "Purchased Assets"):


                                       3
<PAGE>


     (a)  the  testing  equipment,  computers,  motor  vehicles,  furniture  and
furnishings  and  equipment  owned by the  Seller  all of which  are  listed  in
Schedule 1.02(a) (collectively, the "Equipment");

     (b) all of the Seller's title to, interest in and rights under any real and
personal  property  lease relating to the business of Seller to which the Seller
is currently a party,  to the extent such leases are  assignable  (the "Real and
Personal Property Leases") all of which are listed in Schedule 1.02(b);

     (c) goodwill;

     (d) customer lists;

     (e) all of the Seller's rights (and obligations) under the contracts listed
on Schedule  1.02(e) and all of the Seller's  rights and  obligations  under the
Real Property Lease (the "Assumed Obligations");

     (f) the Seller's trade  non-Medicare/Medicaid  accounts receivables (billed
and unbilled)  that have been created since  September 10, 1999, the date of the
Management  Agreement  (the "MA") between the Buyer and the Seller,  which as of
the date of this Agreement is equal to $826,120.20.

     (g) the  Seller's  collections  from  Seller's  Medicare/Medicaid  accounts
receivable  (billed and  unbilled)  that have been created  since  September 10,
1999,  the date of the MA,  which as of the date of this  Agreement  is equal to
$667,937.80.  The Parties agree that the collections will be deposited initially
into an Account owned by the Seller and then will be  transferred  to an account
controlled by Buyer within 24 hours of receipt by Seller.

     (h) all of the  Seller's  rights  with  respect  to a  certain  Non-Compete
Agreement between the Shareholder,  Todd Siegel, Morris Behar, any and all other
employees, and Seller.

     (i) all of the sellers rights with respect to security and other deposits.

     SECTION 1.03. Excluded Assets.  Notwithstanding the foregoing the Seller is
not selling and the Buyer is not purchasing pursuant to this Agreement,  and the
term  "Purchased  Assets"  shall  not  include,  any  of  the  following  assets
(collectively, the "Excluded Assets"):


                                       4
<PAGE>


     (a) accounts  receivable  created  prior to the date of the MA and all cash
collected from such accounts receivable (the "Existing AR");

     (b) any capital stock or equity interest in the Seller;

     (c) all foreign,  federal,  state or local Tax (as defined in Section 9.03)
refunds, Tax refund claims and Tax credits,  deductions or other Tax benefits of
the Seller relating to periods prior to the Closing Date;

     (d) all indemnity and contribution  rights granted to the Seller or owed by
third parties to the Seller with respect to any  Liabilities  not assumed by the
Buyer (as defined in Section 1.04) and any and all rights or assets arising from
and related to the  defense,  release,  compromise,  discharge,  administration,
management or satisfaction by the Seller of the Liabilities;

     (e) all of Seller's  rights,  claims,  actions,  causes of action,  vendor,
supplier and similar  claims,  judgments and demands of whatever nature relating
to Excluded Assets;

     (f) all of Seller's  deferred  charges,  advance  payments,  prepaid items,
claims for  refunds,  rights of  offset,  and  credits  of all  kinds,  relating
specifically to the Excluded Assets;

     (g) the consideration received by the Seller pursuant to this Agreement;

     (h) the Seller's rights to its Medicare provider number; and

     (i) the rights of the Seller under this Agreement.

     SECTION 1.04. Assumption Of Certain Obligations; Excluded Liabilities

     (a) At the  Closing,  the Buyer  shall  assume  and agree to pay,  perform,
fulfill and discharge any and all obligations of the Seller:  (i) to First Union
in an amount not to exceed  $125,000,  (ii) to AmSouth  Bank in an amount not to
exceed $233,000,  (iii) that are set forth on Schedule 1.04, and (iv) that arose
since  September 10, 1999,  (collectively,  the "Assumed  Liabilities")  and the
Assumed Obligations.

     (b) Buyer shall  assume any and all  obligations  secured by the  equipment
acquired pursuant to this Agreement (the "Secured Liabilities").


                                       5
<PAGE>


     (c) Buyer  shall  indemnify,  hold  harmless  and  defend  Seller as to all
losses,  liabilities,  costs and expenses,  including attorney's fees associated
with  the  Assumed   Liabilities,   the  Assumed  Obligations  and  the  Secured
Liabilities (collectively, "Indemnified Expenses").

                                   ARTICLE II

     SECTION  2.01   Consideration.   In   consideration   of  the   Acquisition
contemplated herein, Buyer shall:

     (a) pay to STB (on behalf of the  Seller)  the sum of One  Million  Dollars
($1,000,000),  less the amounts set forth in Section 2.02 below,  at the Closing
(the "Cash Price");

     (b) forgive  any and all  advances or loans made by the Buyer to the Seller
during the term of the MA,  including all principal  amounts and interest on all
such advances and loans;

     (c)  execute  documents  necessary  to assume (or  refinance)  on terms and
conditions acceptable to STB (i) that certain obligation owed to First Union for
an amount not to exceed $125,000, and (ii) that certain obligation in the amount
of $233,000  owed to AmSouth  Bank for an amount not to exceed  $233,000,  which
obligations are currently secured by certain equipment leased by the Seller; and

     (d) execute documents  necessary to assume and pay, as and when due, all of
the remaining Assumed  Liabilities,  Assumed Obligations and Second Liabilities,
pursuant to an  assignment  and  assumption  agreement  contemplated  by Section
1.01(b)(ii).

     SECTION  2.02.  Cash Price  Offsets.  The Buyer shall be entitled to offset
against  the Cash Price the sum of  Seventy-Five  Thousand  and  00/100  Dollars
($75,000.00)  representing  the  deposit  provided  to the  Seller  by the Buyer
pursuant to the Letter of Intent  between the parties  dated  September 10, 1999
(the "Deposit").

                                   ARTICLE III

                  Representations and Warranties of the Seller
                  --------------------------------------------

     The Seller represents and warrants to the Buyer that:


                                       6
<PAGE>

     SECTION 3.01.  Organization and Qualification.  The Seller is a corporation
duly  organized,  validly  existing  and with  active  status  under the laws of
Florida and has the  requisite  power and authority to own or lease its interest
in the  Purchased  Assets  and to  operate  its  properties  and to carry on its
business as it is now being conducted.  The Seller is duly qualified or licensed
as a  foreign  corporation  to do  business,  and is in good  standing,  in each
jurisdiction,  each such  jurisdiction  being listed in Schedule 3.01, where the
character of the properties owned, leased or operated by it or the nature of its
business  makes such  qualification  or licensing  necessary,  except where such
failure to be so duly qualified,  licensed and in good standing would not have a
Material Adverse Effect.

     SECTION  3.02.  Authority  Relative to This  Agreement.  The Seller has all
necessary  corporate  power and authority to execute and deliver this Agreement,
to perform its  obligations  hereunder and to consummate the Acquisition and the
other transactions contemplated by this Agreement. The execution and delivery of
this  Agreement  by the  Seller  has been  duly and  validly  authorized  by all
necessary corporate action and no other corporate proceedings on the part of the
Seller  are  necessary  to  authorize   this  Agreement  or  to  consummate  the
Acquisition.  This Agreement has been duly and validly executed and delivered by
the Seller and,  assuming the due  authorization,  execution and delivery by the
Buyer,  constitutes  a  legal,  valid  and  binding  obligation  of the  Seller,
enforceable  against  the  Seller  in  accordance  with its  terms,  subject  to
applicable bankruptcy,  insolvency and similar laws and to general principles of
equity.

     SECTION 3.03. No Conflict; Required Filings and Consents.

     (a) The  execution  and delivery of this  Agreement by the Seller does not,
and the  performance of this Agreement by the Seller will not, (i) conflict with
or violate the articles of incorporation or by-laws of the Seller; (ii) conflict
with or violate any domestic  (federal,  state or local) or foreign  law,  rule,
regulation,  order, judgment or decree (collectively,  "Laws") applicable to the
Seller or by which any property or  Purchased  Assets of the Seller are bound or
affected,  except for such conflicts or violations which would not, individually
or in the  aggregate,  have a  Material  Adverse  Effect;  or  (iii)  except  as
specified in Schedule  3.03(a)(iii)  of the Disclosure  Schedule,  result in any
breach of or  constitute  a default  (or an event  which with notice or lapse of
time or both  would  become a  default)  under,  or give to others  any right of
termination,  amendment,  acceleration  or  cancellation  of,  or  result in the
creation of a lien or other  encumbrance on any property or Purchased  Assets of
the  Seller  pursuant  to,  any  note,  bond,  mortgage,  indenture,   contract,
agreement,  lease, license,  permit, franchise or other instrument or obligation
to which  the  Seller  is a party or by which  the  Seller  or any  property  or
Purchased  Assets of the  Seller  are  bound or  affected,  except  for any such
breaches,  defaults or other occurrences which would not, individually or in the
aggregate, have a Material Adverse Effect.


                                       7
<PAGE>


     (b) The  execution  and  delivery of this  Agreement  by the Seller and the
consummation  of  the  transactions   contemplated  hereby  does  not,  and  the
performance  of this  Agreement  by the Seller will not,  require  any  consent,
approval,  authorization  or permit of, or filing with or  notification  to, any
governmental or regulatory authority, domestic, foreign or supranational, except
(i) as specified in Schedule 3.03(b) of the Disclosure Schedule;  and (ii) where
failure to obtain such consents,  approvals,  authorizations  or permits,  or to
make such filings or notifications,  would not prevent or delay  consummation of
the  Acquisition,  and  would  not,  individually  or in the  aggregate,  have a
Material Adverse Effect.

     SECTION 3.04. Permits; Seller Products;  Regulation. Except as set forth on
Schedule  3.04 of the  Disclosure  Schedule,  the Seller is in possession of all
franchises,  grants,  authorizations,  licenses, permits, easements,  variances,
exceptions,  consents,  certificates,  approvals  and orders  necessary  for the
Seller to own,  lease and operate its  properties or to carry on its business as
it is now being conducted (the "Permits"),  and no suspension or cancellation of
any of the Permits is pending or, to the  knowledge  of the Seller,  threatened.
Except as provided in Schedule  3.04, the Seller is not in conflict with, nor in
default or violation  of, (i) any Laws  applicable to the Seller or by which any
property or Purchased  Assets of the Seller are bound or  affected;  (ii) any of
the Permits; or (iii) any note, bond, mortgage, indenture,  contract, agreement,
lease, license, permit, franchise or other instrument or obligation to which the
Seller is a party or by which the Seller or any property or Purchased  Assets of
the Seller are bound or  affected,  except for any such  conflicts,  defaults or
violations  that would not,  individually  or in the aggregate,  have a Material
Adverse Effect.

     SECTION  3.05.  Consents.  Except  for the  consents  of STB and the  other
consents that are set forth on Schedule 3.05 of the Disclosure Schedule, neither
the execution, delivery or performance of this Agreement nor the consummation of
any  transaction  provided  for in the  Agreement is  prohibited  by or requires
Seller to obtain or make any consent, authorization,  approval, registration, or
filing under any statute, law, ordinance,  regulation, rule, judgment, decree or
order of any court or governmental agency,  board,  bureau, body,  department or
authority, or of any other person.

     SECTION 3.06.  Absence of  Litigation.  Except as listed in Schedule  3.06,
there is no  claim,  action,  proceeding  or  investigation  pending  or, to the
knowledge of the Seller,  threatened against the Seller or any property or asset
of the Seller before any court, arbitrator or Governmental Authority (as defined
in Section 9.03),  which (a)  individually  or in the  aggregate,  is reasonably
likely to have a Material  Adverse Effect,  or (b) seeks to delay or prevent the
consummation of the Acquisition and the other transactions  contemplated hereby.
Except as listed and briefly  described in Schedule 3.06, as of the date of this
Agreement, neither the Seller nor any Affiliate nor any property or asset of the
Seller  is  subject  to  any  order,   writ,   judgment,   injunction,   decree,
determination  or award having,  individually  or in the  aggregate,  a Material
Adverse Effect.


                                       8
<PAGE>


     SECTION 3.08.  Labor  Matters.  The Seller is not a party to any collective
bargaining  agreement  or other  labor  union  contract  applicable  to  persons
employed by the Seller and has  provided  its  employees  with  notification  of
termination of employment.

     SECTION 3.09. Real Property and Leases.

     (a) To the best of Seller's  knowledge,  the Seller has sufficient title or
leasehold  interests to all its  properties  and Acquired  Assets to conduct its
business as currently  conducted or as contemplated  to be conducted,  with only
such exceptions as, individually or in the aggregate,  would not have a Material
Adverse Effect.

     (b) To the best of Seller's  knowledge,  all leases of real property leased
for the use or benefit  of the  Seller to which the Seller is a party  requiring
rental  payments  in excess of $10,000  during the period of the lease,  and all
amendments and  modifications  thereto are in full force and effect and have not
been  modified or amended,  and there exists no default  under any such lease by
the  Seller,  nor any event  which  with  notice or lapse of time or both  would
constitute a default thereunder by the Seller,  which would,  individually or in
the aggregate, have a Material Adverse Effect.

     SECTION 3.10. Taxes. Except as described in Schedule 3.10 of the Disclosure
Schedule,  (i) the Seller has filed all  federal,  state,  local and foreign Tax
returns and reports required to be filed by it and has paid or accrued all Taxes
shown as due thereon and has paid all  applicable  ad valorem  taxes as are due,
other than (a) such payments as are being contested in good faith by appropriate
proceedings,  a  description  of which is provided in Schedule 3.10 and (b) such
filings,  accruals,  payments or other occurrences that,  individually or in the
aggregate,  would not have a Material Adverse Effect;  (ii) neither the Internal
Revenue Service (the "IRS") nor any other taxing  authority or agency,  domestic
or foreign, is now asserting or, to the knowledge of the Seller,  threatening to
assert  against  the  Seller any  deficiency  or claim for  additional  Taxes or
interest  thereon  or  penalties  in  connection  therewith,   which  claims  or
deficiencies,  individually or in the aggregate,  would have a Material  Adverse
Effect;  (iii)  the  Seller  has  not  granted  any  waiver  of any  statute  of
limitations with respect to, or any extension of a period for the assessment of,
any federal,  state, county,  municipal or foreign income tax; (iv) the accruals
and  reserves  for Taxes  reflected  in the Closing  Balance  Sheet and the most
recent quarterly financial  statements are adequate to cover all taxes accruable
through the date thereof (including interest and penalties,  if any, thereon) in
accordance with generally accepted  accounting,  principles;  (v) Seller has not
withheld or collected and paid over to the appropriate  Governmental authorities
or are  properly  holding  for such  payment  all  Taxes  required  by law to be
withheld or collected, except for such failures to have so withheld or collected
and paid over or to be so holding for payment which would not,  individually  or
in the  aggregate,  have a  Material  Adverse  Effect;  and  (vii)  there are no
material  liens for Taxes  upon the assets of the  Seller,  other than liens for
Taxes  that  are  being  contested  in good  faith  by  appropriate  proceedings
described in Schedule 3.10.


                                       9
<PAGE>


     SECTION 3.11. Environmental Matters.

     (a) For  purposes of this  Agreement,  the  following  terms shall have the
following meaning: (i) "Hazardous Substances" means (A) those substances defined
in or regulated  under the following  U.S.  federal  statutes and their state or
foreign  counterparts,  as  each  may be  amended  from  time to  time,  and all
regulations thereunder: the Hazardous Materials Transportation Act, the Resource
Conservation  and  Recovery  Act,  the  Comprehensive   Environmental  Response,
Compensation  and Liability  Act, the Clean Water Act, the Safe  Drinking  Water
Act,  the Toxic  Substances  Control Act,  the Marine  Protection,  Research and
Sanctuaries Act, the Atomic Energy Act, the Federal Insecticide,  Fungicide, and
Rodenticide  Act and the Clean Air Act; (B)  petroleum  and  petroleum  products
including crude oil and any fractions  thereof,  (C) natural gas, synthetic gas,
and any mixtures  thereof,  (D) radon; (E) asbestos;  (F) any other pollutant or
contaminant;  and (G) any  substance  with respect to which a federal,  state or
local agency requires environmental  investigation,  monitoring,  reporting,  or
remediation;  and (ii)  "Environmental  Laws" means any U.S. or foreign federal,
state or local law relating to (A) releases or threatened  releases of Hazardous
Substances or materials  containing Hazardous  Substances;  (B) the manufacture,
handling, transport, use, treatment, storage or disposal of Hazardous Substances
or materials  containing  Hazardous  Substances;  or (C)  otherwise  relating to
pollution of the environment or the protection of human health.

     (b) To the knowledge of the Seller, except as described in Schedule 3.11 of
the  Disclosure  Schedule  (which  description  shall include an estimate of the
Seller's potential financial liability with respect to each matter so described)
or as would not,  individually  or in the  aggregate,  have a  Material  Adverse
Effect:  (i)  the  Seller  has  not  violated  and is not  in  violation  of any
Environmental  Law; (ii) there has been no  contamination,  disposal,  spilling,
dumping,  incineration,   discharge,  storage,  treatment  or  handling  of  any
Hazardous  Substance,  on or from any of the  properties  owned or leased by the
Seller  (including,  without  limitation,  soils and surface and ground waters);
(iii) to the  knowledge of the Seller,  the Seller is not liable for any offsite
contamination; (iv) the Seller is not liable under any Environmental Law; (v) to
the  knowledge  of the Seller,  the Seller has all  permits,  licenses and other
authorizations  required under any Environmental Law ("Environmental  Permits");
(vi) to the  knowledge of the Seller,  the Seller has been and is in  compliance
with its  Environmental  Permits;  and (vii)  there are no  pending,  or, to the
knowledge of the Seller,  threatened claims against the Seller or any Subsidiary
relating to any Environmental Law or Hazardous Substance.


                                       10
<PAGE>

     SECTION  3.12.  Vote  Required.  The  affirmative  vote of the holders of a
majority of the  outstanding  shares of Seller  Common Stock is the only vote of
the holders of any class or series of capital  stock of the Seller  necessary to
approve the Acquisition.

     SECTION 3.13. Brokers.  No broker,  finder or investment banker is entitled
to any  brokerage,  finder's or other fee or commission  in connection  with the
Acquisition based upon arrangements made by or on behalf of the Seller.

     SECTION 3.14. Bylaws.  Seller has provided Buyer with copies of the by-laws
of Seller.

     All of the above  representations  and warranties  shall be true both as of
the date of the execution of this Agreement and as of the Closing Date.


                                   ARTICLE IV

                     Representations and Warranties of Buyer

     Buyer hereby represents and warrants to the Seller that:

     SECTION 4.01.  Organization and Qualification.  Buyer is a corporation duly
organized, validly existing and with active status under the laws of Florida and
has the requisite  power and authority to own,  lease and operate its properties
and to carry on its  business  as it is now being  conducted,  except  where the
failure to be so  organized,  existing or in good standing or to have such power
and  authority  would not,  individually  or in the  aggregate,  have a Material
Adverse Effect.  Buyer is duly qualified or licensed as a foreign corporation to
do business,  and is in good standing,  in each jurisdiction where the character
of the properties owned,  leased or operated by it or the nature of its business
makes such qualification or licensing necessary,  except for such failures to be
so qualified or licensed and in good standing,  that would not,  individually or
in the aggregate, have a Material Adverse Effect.

     SECTION 4.02.  Articles of Incorporation and By-Laws.  Buyer has heretofore
furnished  to the  Seller  a  complete  and  correct  copy  of its  articles  of
incorporation  and by-laws,  each as amended to date, of Buyer. Such articles of
incorporation  and  by-laws  are in  full  force  and  effect.  Buyer  is not in
violation of any provision of its articles of incorporation or by-laws.


                                       11
<PAGE>

         SECTION  4.03.  Authority  Relative  to this  Agreement.  Buyer has all
necessary  corporate  power and authority to execute and deliver this Agreement,
to perform its  obligations  hereunder and to consummate the Acquisition and the
other  transactions  contemplated  hereby.  The  execution  and delivery of this
Agreement by Buyer and the  consummation by Buyer of the  Acquisition  have been
duly and  validly  authorized  by all  necessary  corporate  action and no other
corporate  proceedings  on the part of Buyer are  necessary  to  authorize  this
Agreement or to consummate  the  Acquisition.  This  Agreement has been duly and
validly  executed and  delivered by Buyer and,  assuming the due  authorization,
execution  and delivery by the Seller,  constitutes  a legal,  valid and binding
obligation of Buyer  enforceable  against  Buyer in  accordance  with its terms,
subject to applicable  bankruptcy,  insolvency,  and similar laws and to general
principles of equity.

     SECTION 4.04. No Conflict; Required Filings and Consents.

     (a)  The  execution  and  delivery  of  this  Agreement  by  Buyer  and the
consummation  of the  transactions  contemplated by this Agreement does not, and
the  performance  of this  Agreement  by Buyer will not,  (i)  conflict  with or
violate the articles of incorporation or by-laws of Buyer; (ii) conflict with or
violate  any Law  applicable  to Buyer or by which any  property or asset of the
Buyer is bound or affected,  except for such conflicts or violations which would
not individually or in the aggregate,  have a Material Adverse Effect;  or (iii)
except as specified in Schedule 4.04(a)(iii) of the Disclosure Schedule,  result
in any breach of or constitute a default (or an event which with notice or lapse
of time or both would become a default)  under,  or give to others any rights of
termination,  amendment,  acceleration  or  cancellation  of,  or  result in the
creation  of a lien or  other  encumbrance  on any  property  or  asset of Buyer
pursuant to, any note, bond, mortgage,  indenture,  contract,  agreement, lease,
license,  permit, franchise or other instrument or obligation to which the Buyer
is a party or by which the Buyer or any  property  or asset of Buyer is bound or
affected,  except for any such  breaches,  defaults or other  occurrences  which
would not, individually or in the aggregate, have a Material Adverse Effect.

     (b) The  execution  and  delivery  of this  Agreement  by the Buyer and the
consummation  of the  transactions  contemplated by this Agreement does not, and
the  performance  of this  Agreement  by Buyer will not,  require  any  consent,
approval,  authorization  or permit of, or filing with or  notification  to, any
Governmental or regulatory authority, domestic, foreign or supranational, except
(i) as specified in Schedule 4.04(b) of the Disclosure Schedule;  and (ii) where
failure to obtain such consents,  approvals,  authorizations  or permits,  or to
make such filings or notifications,  would not prevent or delay  consummation of
the  Acquisition,  and  would  not,  individually  or in the  aggregate,  have a
Material Adverse Effect.


                                       12
<PAGE>

     SECTION 4.05. Consents.

     (a)  Except  as set  forth on  Schedule  4.05 of the  Disclosure  Schedule,
neither  the  execution,  delivery  or  performance  of this  Agreement  nor the
consummation of any  transaction  provided for in the Agreement is prohibited by
or requires  the Buyer to obtain or make any consent,  authorization,  approval,
registration,  or filing under any statute,  law, ordinance,  regulation,  rule,
judgment,  decree or order of any court or governmental  agency,  board, bureau,
body, department or authority, or of any other person. The Buyer is not required
to file any form, report or other document with the SEC.

     (b) Except as and to the extent set forth on the consolidated balance sheet
of the Buyer as at September  10, 1999 , including the notes thereto (the "Buyer
Balance  Sheet"),  the Buyer does not have any  liability or  obligation  of any
nature  (whether  accrued,  absolute,  contingent or  otherwise)  which would be
required to be reflected on a balance sheet,  or in the notes thereto,  prepared
in  accordance  with  generally  accepted  accounting  principles,   except  for
liabilities  and  obligations  (i)  incurred in the  ordinary  course of Buyer's
business  since  September  10,  1999 which  would not,  individually  or in the
aggregate,  have a Material Adverse Effect;  and (ii) incurred  pursuant to this
Agreement.

     SECTION 4.06.  Absence of Certain  Changes or Events.  Since  September 10,
1999 , except as  contemplated  by this  Agreement,  or as set forth in Schedule
4.06 of the  Disclosure  Schedule,  Buyer has  conducted  its  businesses in the
ordinary  course  and in a manner  consistent  with  past  practice  and,  since
September  10,  1999 ,  there  has not  been (a) any  event  or  events  having,
individually or in the aggregate,  a Material Adverse Effect,  (b) any change by
the  Buyer  in  its  accounting  methods,   principles  or  practices,  (c)  any
revaluation  by the  Buyer of any  asset  (including,  without  limitation,  any
writing  down of the value of  inventory  or  writing  off of notes or  accounts
receivable),  other than in the ordinary course of business consistent with past
practice, (d) any entry by the Buyer into any commitment or transaction material
to the Buyer, except in the ordinary course of business and consistent with past
practice,  or (e) any  declaration,  setting aside or payment of any dividend or
distribution  in  respect  of any  capital  stock of  Buyer  or any  redemption,
purchase or other acquisition of any of its securities.

     SECTION 4.07.  Absence of Litigation.  Except as disclosed in Schedule 4.07
of  the  Disclosure  Schedule,   there  is  no  claim,  action,   proceeding  or
investigation pending or, to the knowledge of the Buyer,  threatened against the
Buyer,  or any property or asset of the Buyer,  before any court,  arbitrator or
Governmental  Authority (as defined in Section 9.03),  which (a) individually or
in the aggregate, is reasonably likely to have a Material Adverse Effect, or (b)
seeks to delay or prevent  the  consummation  of the  Acquisition  and the other
transactions contemplated hereby. Neither the Buyer nor any property or asset of
the  Buyer  is  subject  to  any  order,  writ,  judgment,  injunction,  decree,
determination  or award having,  individually  or in the  aggregate,  a Material
Adverse Effect.


                                       13
<PAGE>


     SECTION 4.08. Brokers.  No broker,  finder or investment banker is entitled
to any  brokerage,  finder's or other fee or commission  in connection  with the
Acquisition based upon arrangements made by or on behalf of the Buyer.

     SECTION  4.09  Medicare.  The Buyer has  applied  for a  Medicare  provider
number.  Buyer reasonably  expects it will be issued a Medicare  provider number
and state license, if applicable,  on or before 180 days after the Closing Date.
Buyer believes that it satisfies all statutory and regulatory  requirements  for
obtaining  a  Medicare  provider  number.  Borrower  knows of no reason  why its
application would be denied and neither Buyer nor any affiliate of Buyer has any
history of  regulatory  problems  with  Medicare,  Medicaid or similar  state or
federal agencies. Buyer upon request, will provide to Seller a written status of
its Medicare application.

     SECTION 4.10 Certain Matters.

     (a) The Buyer has obtained a binding commitment from First Union for a line
of credit  (the  "Line")  in the  amount of Nine  Hundred  Twenty-Five  Thousand
Dollars ($925,000),  a copy of which is attached to this Agreement as Exhibit C.
Taking the Line into account,  the Buyer has adequate  funds to pay the Purchase
Price to the Buyer.

     (b) The Buyer is not insolvent  and the  consummation  of the  transactions
contemplated by this Agreement shall not cause the Buyer to become insolvent.

     SECTION 4.11 Licenses

     The Buyer has  applied  for all  applicable  state  and  federal  licenses.
Borrower  believes that it satisfies all statutory and  regulatory  requirements
for obtaining of all applicable  state and federal  licenses.  Buyer knows of no
reason why its applications  would be denied and neither Buyer nor any affiliate
of Buyer has any  history  of  regulatory  problems  with any  state or  federal
agencies.

     All of the above  representations  and warranties  shall be true both as of
the date of the execution of this Agreement and as of the Closing Date.


                                       14
<PAGE>

                                    ARTICLE V

                   CONDUCT OF BUSINESS PENDING THE ACQUISITION
                   -------------------------------------------

     SECTION 5.01.  Conduct of Business by the Seller  Pending the  Acquisition.
The Seller covenants and agrees that, between the date of this Agreement and the
earlier of the  termination  of this  Agreement or the Closing Date,  unless the
Buyer shall  otherwise  agree in writing,  the businesses of the Seller shall be
conducted  only in,  and the  Seller  shall not take any  action  except in, the
ordinary course of business and in a manner  consistent with past practice;  and
the Seller shall use commercially  reasonable efforts to preserve  substantially
intact its business organization,  to keep available the services of the current
officers,  employees and  consultants  of the Seller and to preserve the current
relationships  of the Seller with  customers,  suppliers  and other persons with
which  the  Seller  has  significant  business  relations.  It is  acknowledged,
however,  that any action taken by the Buyer on behalf of the Seller pursuant to
the MA or  otherwise,  shall not be deemed to be in  violation  of this  Section
5.01. By way of amplification and not limitation, except as contemplated by this
Agreement  or as set  forth  in  Schedule  5.01 of the  Disclosure  Schedule  or
otherwise contemplated by the MA, the Seller shall not, between the date of this
Agreement and the earlier of the  termination  of this  Agreement or the Closing
Date,  directly or indirectly do, or propose to do, any of the following without
the prior written consent of the Buyer:

     (a) amend or otherwise  change the Seller's  articles of  incorporation  or
by-laws;

     (b) issue,  sell,  pledge,  dispose of, grant,  encumber,  or authorize the
issuance, sale, pledge,  disposition,  grant or encumbrance of any assets of the
Seller,  except for sales in the  ordinary  course of  business  and in a manner
consistent with past practice (if any);

     (c) declare,  set aside,  make or pay any  dividend or other  distribution,
payable  in cash,  stock,  property  or  otherwise,  with  respect to any of its
capital stock;

     (d) acquire (including,  without limitation, by merger,  consolidation,  or
acquisition  of stock or assets) any  corporation,  partnership,  other business
organization  or any  division  thereof or any material  amount of assets;  (ii)
incur  any  indebtedness  for  borrowed  money or issue any debt  securities  or
assume,   guarantee  or  endorse,  or  otherwise  as  an  accommodation   become
responsible  for, the obligations of any person,  or make any loans or advances,
except in the ordinary  course of business and  consistent  with past  practice;
(iii) enter into any contract or agreement material to the business,  results of
operations  or  financial  condition  of the Seller,  other than in the ordinary
course of business,  consistent  with past  practice;  (iv) authorize any single
capital expenditure which is in excess of $10,000 or capital  expenditures which
are, in the aggregate,  in excess of $25,000 ; or (v) enter into or amend in any
material respect any contract, agreement, commitment or arrangement with respect
to any matter set forth in this  subsection (d) (except any agreement with STB);
or


                                       15
<PAGE>


     (e) increase the compensation  payable or to become payable to its officers
or employees generally,  or grant any bonus, severance or termination pay to, or
enter into any employment or severance  agreement with any director,  officer or
other  employee  of the Seller,  or  establish,  adopt,  enter into or amend any
collective  bargaining,  bonus,  profit  sharing,  thrift,  compensation,  stock
option,   restricted  stock,   pension,   retirement,   deferred   compensation,
employment, termination, severance or other plan, agreement, trust, fund, policy
or arrangement for the benefit of any director, officer or employee.


                                       16
<PAGE>

                                   ARTICLE VI

                              ADDITIONAL AGREEMENTS
                              ---------------------

     SECTION 6.01. Appropriate Action; Consents; Filings.

     (a) The Seller and the Buyer shall use commercially  reasonable  efforts to
(i) take, or cause to be taken, all appropriate  action,  and do, or cause to be
done,  all  things  necessary,  proper  or  advisable  under  applicable  Law or
otherwise  to  consummate  and make  effective  the  Acquisition  as promptly as
practicable;  (ii) obtain in a timely manner from any  Governmental  Authorities
any consents,  licenses, permits, waivers,  approvals,  authorizations or orders
required  to be  obtained  or made by the  Buyer or the  Seller  or any of their
subsidiaries  in connection  with the  authorization,  execution and delivery of
this  Agreement  and  the   consummation   of  the  Acquisition  and  the  other
transactions  contemplated hereby; and (iii) as promptly as practicable make all
necessary  filings,  and thereafter  make any other required  submissions,  with
respect to this Agreement and the Acquisition required under any applicable Law;
provided  that the Buyer  and the  Seller  shall  cooperate  with each  other in
connection  with the making of all filings,  including  providing  copies of all
such  documents to  non-filing  party and its  advisors  prior to filing and, if
requested, to accept all reasonable additions, deletions or changes suggested in
connection  therewith.  The Seller and the Buyer shall furnish to each other all
information  required for any application or other filing to be made pursuant to
the  rules  and  regulations  of any  applicable  Law  in  connection  with  the
transactions contemplated by this Agreement.

     (b) (i) Each of the Buyer and the  Seller  shall  give (or shall  cause its
respective  subsidiaries  to give) any notices to third  parties,  and use,  and
cause its respective  subsidiaries to use, their commercially reasonable efforts
to obtain any third  party  consents,  (A)  necessary,  proper or  advisable  to
consummate the  transactions  contemplated in this  Agreement,  (B) disclosed or
required to be disclosed in the Disclosure Schedule or (C) required to prevent a
Material Adverse Effect from occurring prior to or after the Closing Date.

          (ii) In the event that  either  the Buyer or the Seller  shall fail to
     obtain any third party  consent  described in subsection  (b)(i) above,  it
     shall use its  commercially  reasonable  efforts,  and shall  take any such
     actions  reasonably  requested by the other party,  to minimize any adverse
     effect upon the Seller and the Buyer,  their respective  subsidiaries,  and
     their  respective  businesses  resulting,  or  which  could  reasonably  be
     expected to result after the Closing Date,  from the failure to obtain such
     consent.

                                       17
<PAGE>


     (c) Each party  shall  promptly  notify  the other  party in writing of any
pending or threatened  action,  proceeding or  investigation by any Governmental
Authority or any other person (i)  challenging or seeking,  material  damages in
connection  with the  Acquisition;  or (ii)  seeking to restrain or prohibit the
consummation  of the  Acquisition  or  otherwise  limit the  right of Buyer,  or
Buyer's Subsidiaries,  to own or operate all or any portion of the businesses or
Acquired Assets.

     SECTION 6.02. Access to Information; Confidentiality; Investigation.

     (a) Upon  reasonable  notice  and  subject  to  restrictions  contained  in
confidentiality agreements to which such party is subject (from which such party
shall use  commercially  reasonable  efforts to be released),  the Buyer and the
Seller  will each  provide to the other (and their  respective  representatives)
reasonable  access,  to all  information  and  documents  which  the  other  may
reasonably request regarding the business,  assets,  liabilities,  employees and
other aspects of the other,  other than  information  and documents  that in the
opinion of such other party's counsel may not be disclosed under applicable law.
Each party shall keep such  information  confidential in accordance with Section
6.07  hereof  and  such  obligations  shall  survive  the  Closing  Date  or any
termination of this Agreement.

     (b) The Buyer has conducted its own investigation of the Purchased Business
and is not relying on any representation, warranty or assurance (whether oral or
written, express or implied) of the Seller not contained in this Agreement.

     SECTION 6.03. Directors' and Officers' Indemnification and Insurance.

     (a)  After the  Closing  Date,  the  Buyer  shall,  to the  fullest  extent
permitted  under  applicable  law or  under  the  Buyer's,  as the  case may be,
articles of incorporation or bylaws,  indemnify and hold harmless,  each present
and former employee of the Seller or any of its subsidiaries  (each a "Potential
Indemnified   Party")  against  any  reasonable  costs  or  expenses  (including
reasonable  attorneys'  fees),   judgments,   fines,  losses,  claims,  damages,
liabilities and amounts paid in settlement in connection with any claim, action,
suit, proceeding or investigation,  whether civil,  criminal,  administrative or
investigative  (collectively,  "Losses"),  arising out of or  pertaining  to any
action or omission by such party  within the scope of such  employee's  official
capacity with the Seller occurring during the term of the MA (including  without
limitation,  the  transactions  contemplated  by this Agreement) for a period of
three years after the date hereof and related to the matters governed by the MA,
provided,  however,  that the Buyer shall not be required to  indemnify  or hold
harmless any Potential  Indemnified  Party (i) for any Losses  arising out of or
pertaining  to any  acts  or  omissions  of  such  Potential  Indemnified  Party
determined in any judicial proceeding to be intentional  misconduct or a knowing
violation  of law, or with  respect to which it is  determined  in any  judicial
proceeding that such Potential  Indemnified Party personally  received a benefit
in money,  property or services to which such Potential Indemnified Party is not
legally  entitled;  (ii) to the extent that the Buyer  determines  in good faith
that it would not indemnify or hold harmless any similarly  situated employee of
the Buyer or any of its wholly-owned  subsidiaries under similar  circumstances;
or (iii) to the extent that the Buyer  reasonably  determines that the Potential
Indemnified  Party did not  reasonably  believe  that the action or  omission in
question  was in the  Buyer's  best  interest.  In the event of any such  claim,
action, suit,  proceeding or investigation  (whether arising before or after the
Closing  Date),  (A) the  Buyer  shall be  permitted  to select  counsel  of its
choosing  to conduct  the defense of such claim,  action,  suit,  proceeding  or
investigation,  (B) after the Closing Date,  the Buyer shall pay the  reasonable
fees and  expenses of such  counsel,  promptly  after  statements  therefor  are
received  unless  the  Buyer  determines  that one or more of the  circumstances
described in any of (i) through (iii) of the previous  sentence is present,  and
(C) the Buyer and the Potential  Indemnified Party will cooperate in the defense
of any such matter.


                                       18
<PAGE>

     (b) This Section 6.03 shall survive the  consummation of the Acquisition at
the Closing Date,  is intended to benefit the Seller,  the Buyer and the present
and former  directors  and officers of the Seller (the  "Indemnified  Parties"),
shall be binding,  jointly and  severally,  on all successors and assigns of the
Buyer, and shall be enforceable by the Indemnified Parties.

     SECTION  6.04.  Notification  of Certain  Matters.  Each party hereto shall
promptly  notify  the other  party  hereto by written  update to its  Disclosure
Schedule of (a) the occurrence,  or nonoccurrence,  of any event the occurrence,
or  nonoccurrence  of which would be likely to cause (i) any  representation  or
warranty made in this Agreement by such party, or any  information  furnished on
any  Schedule  in the  Disclosure  Schedule  by  such  disclosing  party,  to be
inaccurate  either at the time such  representation or warranty is made, or such
information is furnished,  or at the time of the occurrence or non-occurrence of
such  event;  or (ii) any  failure by such party to comply  with or satisfy  any
condition to the  obligations  of such party to effect the  Acquisition  and the
other  transactions  contemplated by this  Agreement,  or (b) the failure of the
Seller or the Buyer, as the case may be, to comply with or satisfy any covenant,
condition or  agreement to be complied  with or satisfied by it pursuant to this
Agreement which would be likely to result in any condition to the obligations of
any party to effect the Acquisition and the other  transactions  contemplated by
this Agreement not to be satisfied;  provided, however, that the delivery of any
notice  pursuant to this  Section 6.04 shall not be deemed to be an amendment of
this Agreement or any Schedule in the Disclosure Schedule and shall not cure any
breach of any  representation  or warranty  requiring  disclosure of such matter
prior to the date of this Agreement.  No delivery of any notice pursuant to this
Section 6.04 shall limit or affect the remedies available hereunder to the party
receiving such notice,  including the rights of the Buyer under Section  7.02(a)
and those of the Seller under Section 7.03(a) in the event that a representation
or warranty made by the Seller or the Buyer herein shall not be true and correct
(giving effect to any standards of materiality set forth in such sections) as of
the Closing Date.


                                       19
<PAGE>

     SECTION  6.05.  Announcements.  The Buyer and the Seller shall consult with
each other  before  issuing  any press  release or  otherwise  making any public
statements  with  respect  to this  Agreement  or the  Acquisition  and  related
transactions  and shall not issue any such press release or make any such public
statement  prior to such  consultation,  except as may be required  by Law.  The
parties  will agree on the text of a joint press  release by which Buyer and the
Seller will announce the execution of this Agreement.

     SECTION  6.06.  Confidentiality.  At all times  from and after the  Closing
Date,  the Seller  shall keep secret and maintain in  strictest  confidence  and
shall  not  use for its  benefit  or for the  benefit  of any  third  party  any
confidential or proprietary  information:  (i) disclosed by the Buyer during the
period of  negotiations  for this  Agreement and after the Closing Date, or (ii)
relating  to  the  Purchased  Business,   including,   without  limitation,  all
Intellectual Property and files and records,  other than any of such information
that is in the public  domain prior to the date of this  Agreement or thereafter
comes into the public domain (unless any of such information is in or becomes in
the public domain in whole or in part due to action or inaction of the Seller in
violation  of this  Agreement).  The  foregoing  shall not  prohibit use of such
information as is required by applicable  law, or as is necessary to prepare Tax
Returns or other filings with governmental authorities for the period (including
all prior taxable  years) ending on and including the Closing Date, or to assert
or protect  any rights of the Seller  under this  Agreement,  provided  that the
Buyer is given notice and an adequate  opportunity to contest such disclosure or
to use any means reasonably available to minimize such disclosure.

     SECTION  6.07  Conduct of Business  Pending  Buyer  Obtaining  New Medicare
Provider Number.

     From the Closing until Buyer obtains its own  validated  Medicare  provider
number or the date on which the MA and the Lease terminate  pursuant to the next
paragraph of this Section 6.07, whichever occurs first, Seller shall continue to
operate  business  under the MA and the Lease.  When the Buyer  obtains  its own
validated  Medicare  provider  number  the  Lease  and the MA shall  immediately
terminate.

     In the event (a)  Buyer  does not  obtain  its own new  validated  Medicare
provider number within six (6) months from the date of the Closing, or (b) Buyer
receives a final  notification that it has been denied its new Medicare provider
number,  whichever  occurs  first,  the Buyer  shall take an  assignment  of the
Seller's  Medicare  provider  number  and the  Lease  and MA  shall  immediately
terminate.


                                       20
<PAGE>

     On  termination  of the MA and Lease,  the Lease payments shall be prorated
through the date of  termination  and the  payments  pursuant to the MA shall be
prorated  through  the date of  termination  and  Seller  shall  have no further
liability under the MA.

     Buyer agrees to indemnify and hold Seller and Shareholder harmless from any
and all damages, losses, expenses,  liability or claims of any manner whatsoever
concerning  the operation of the  Purchased  Assets from the date of the Closing
until the date on which Buyer obtains its own Medicare provider number.

     SECTION 6.09 Employee Benefit Plans. Seller will terminate all Plans on the
Closing  Date and that Buyer has no  obligation  to maintain any Plans after the
Closing Date.

                                   ARTICLE VII

                          CONDITIONS TO THE ACQUISITION
                          -----------------------------

     SECTION 7.01.  Conditions to the Obligations of Each Party. The obligations
of the  Seller  and Buyer to  consummate  the  Acquisition  are  subject  to the
satisfaction of the following conditions:

     (a) all  actions by or in respect  of, or filings  with,  any  Governmental
Authority required to permit the consummation of the Acquisition shall have been
obtained  (other than those  actions or filings  which,  if not obtained or made
prior to the consummation of the Acquisition, would not have, individually or in
the aggregate,  a Material  Adverse Effect prior to or after the Closing Date or
be  reasonably  likely  to  subject  the  Seller  or the  Buyer  or any of their
respective  subsidiaries  or any of their  respective  officers or  directors to
substantial penalties or criminal liability); and

     (b) this Agreement, and all related documents, shall be approved by STB.

     SECTION 7.02.  Conditions to the Obligations of the Buyer.  The obligations
of the Buyer to consummate the  Acquisition  are subject to the  satisfaction of
the following, further conditions:


                                       21
<PAGE>

     (a) (i) the Seller shall have performed in all material respects all of its
obligations  under this Agreement  required to be performed by it at or prior to
the Closing Date; (ii) each of the  representations and warranties of the Seller
contained in this Agreement  which is qualified as to materiality  shall be true
and correct and each such  representation  and warranty that is not so qualified
shall be true and  correct  in all  material  respects,  in each  case as of the
Closing Date as if made at and as of such time, except (A) for changes permitted
by this Agreement,  and (B) that the  representations and warranties made by the
Seller in Section 3.03 which address  matters only as of a particular date shall
remain true and correct as of such date;  and (iii) Buyer shall have  received a
certificate  signed by an  executive  officer  of the  Seller to the  foregoing,
effect;

     (b) the Seller  shall have  obtained the consent or approval of each person
whose consent or approval shall be required in connection  with the  Acquisition
under all notes, bonds, mortgages,  indentures,  contracts,  agreements, leases,
licenses,  permits,  franchises and other instruments or obligations to which it
or any of its subsidiaries is a party.

     (c) no order, stay, decree, judgment or injunction shall have been entered,
issued  or  enforced  by  any  Governmental  Authority  or  court  of  competent
jurisdiction  which prohibits  consummation of the Acquisition,  and there shall
not be any action taken,  or any statute,  rule,  regulation  or order  enacted,
entered,  enforced  or deemed  applicable  to the  Acquisition,  which makes the
consummation of the Acquisition  illegal or substantially  deprives the Buyer of
any of the expected benefits of the Acquisition or the related transactions.

     SECTION 7.03.  Conditions to the Obligations of the Seller. The obligations
of the Seller to consummate the Acquisition  are subject to the  satisfaction of
the following further conditions:

     (a) (i) The Buyer shall have performed in all material  respects all of its
obligations  with this  Agreement  required to be performed by it at or prior to
the Closing Date; (ii) the representations and warranties of the Buyer contained
in this Agreement and any  certificate  or other writing  delivered by the Buyer
pursuant  hereto which is qualified as to materiality  shall be true and correct
and each such representation and warranty that is not so qualified shall be true
and correct in all material respects,  in each case as of the date hereof and at
and as of the  Closing  Date as if made at and as of such  time,  except (A) for
changes  permitted  by this  Agreement,  and (B)  that the  representations  and
warranties  made by the Buyer in Article IV which  address  matters only as of a
particular  date shall  remain true and  correct as of such date;  and (iii) the
Seller shall have received a certificate  signed by an executive  officer of the
Buyer to the foregoing effect;

     (b) The Buyer  shall have  obtained  the consent or approval of each person
whose consent or approval shall be required in connection  with the  Acquisition
under all notes, bonds, mortgages,  indentures,  contracts,  agreements, leases,
licenses,  permits,  franchises and other instruments or obligations to which it
or any of its subsidiaries is a party,  except those for which failure to obtain
such consents and approvals would not be reasonably  expected to have a Material
Adverse Effect after the Closing Date;


                                       22
<PAGE>

     (c) No order, stay, decree, judgment or injunction shall have been entered,
issued or enforced by any Governmental Authority court of competent jurisdiction
which  prohibits  consummation  of the  Acquisition,  and there shall not be any
action  taken,  or any statute,  rule,  regulation  or order  enacted,  entered,
enforced or deemed  applicable to the Acquisition,  which makes the consummation
of the Acquisition illegal.

     (d)  First  Union  and  AmSouth  Bank  shall  release  the  Seller  and the
Shareholder,  in a form  acceptable  in all  respects  to STB the Seller and the
Shareholder, from all obligations owed to First Union or any of its affiliates.

     (e) The  landlord  under  the Real  Property  Lease  shall  consent  to the
assignment  and  assumption  of such  lease and shall  release  Seller  from all
obligations thereunder.

                                  ARTICLE VIII

                        TERMINATION, AMENDMENT AND WAIVER
                        ---------------------------------

     SECTION  8.01.  Termination.  This  Agreement  may be  terminated  and  the
Acquisition   may  be  abandoned  at  any  time  prior  to  the  Closing   Date,
notwithstanding,  any requisite  approval and adoption of this Agreement and the
transactions contemplated hereby:

     (a) by mutual written consent duly authorized by the Boards of Directors of
each of Buyer and the Seller; or

     (b) by either  Buyer or the Seller if either (i) the Closing Date shall not
have occurred on or before January 1, 2000, provided, however, that the right to
terminate  this Agreement  under this Section  8.01(b) shall not be available to
any party whose failure to fulfill any obligation  under this Agreement has been
the cause of, or resulted  in, the  failure of the  Closing  Date to occur on or
before such date, or (ii) there shall be any Law that makes  consummation of the
Acquisition  illegal  or  otherwise  prohibited  or if any  court  of  competent
jurisdiction  or  Governmental  Authority  shall have  issued an order,  decree,
ruling or taken any other action restraining, enjoining or otherwise prohibiting
the Acquisition and such order, decree, ruling or other action shall have become
final and  nonappealable;  provided  that the party  seeking to  terminate  this
Agreement  pursuant to this  subsection  (b)(ii)  shall have  complied  with its
obligations  under Sections  6.01(a) and (b) of this  Agreement,  subject to the
terms of Section 6.01(c); or

                                       23
<PAGE>

     (c) by the Seller pursuant to immediately  effective written notice, in the
event of a  material  breach by the  Buyer of any  representation,  warranty  or
agreement  contained herein which has not been cured or is not curable within 45
days of notice (or such later date as provided in subparagraph (b) above); or

     (d) by the Buyer,  in the event of a  material  breach by the Seller or any
subsidiary of any  representation,  warranty or agreement contained herein which
has not been  cured or is not  curable  within 45 days of notice  (or such later
date as provided in subparagraph (b) above).

     SECTION 8.02. Effect of Termination. Except as provided in Section 9.01 and
Sections  6.02 and  6.07,  in the  event of the  termination  of this  Agreement
pursuant to Section 8.01, this Agreement shall forthwith  become void and the MA
shall  terminate.  However,  within ten days of  termination  there  shall be an
accounting of all monies received,  expended and loaned pursuant to the terms of
the MA. Upon  completion of that  accounting,  the parties shall within five (5)
days  therof  deliver to the other all sums of money  found to be due the other.
Provided,  however, the $75,000 earnest money deposit from Buyer to Seller shall
be  immediately  repaid to Buyer if this  Agreement is  terminated  because of a
material breach or default by the Seller.

     SECTION 8.03. Expenses. As used herein, "Expenses" means all reasonable and
documented  out-of-pocket  expenses and fees  incurred by the Buyer,  on the one
hand,  or the  Seller,  on the  other  hand,  prior to the  termination  of this
Agreement  (including,  without  limitation,  all fees and  expenses of counsel,
financial advisors, accountants, environmental and other experts and consultants
to the Buyer or the Seller,  and their affiliates,  as the case may be) actually
incurred  or  accrued  by  them  or on  their  behalf  in  connection  with  the
Acquisition,  and actually  incurred or accrued by any of the foregoing  persons
and assumed by the Buyer or the Seller or their affiliates,  as the case may be,
in connection  with the  negotiation,  preparation,  execution,  performance and
termination  of this  Agreement,  the  structuring  of the  Acquisition  and any
agreements relating thereto. Except as set forth in this Section 8.03, all costs
and expenses  incurred in connection  with this  Agreement  and the  Acquisition
shall  be  paid  by the  party  incurring  such  expenses,  whether  or not  the
Acquisition is consummated.

     SECTION 8.04. Amendment.  This Agreement may be amended by an instrument in
writing signed by the parties hereto.

                                       24
<PAGE>


     SECTION  8.05.  Waiver.  At any time prior to the Closing  Date,  any party
hereto may (a) extend the time for the  performance  of any  obligation or other
act of any other party hereto,  (b) waive any inaccuracy in the  representations
and warranties contained herein or in any document delivered pursuant hereto and
(c) waive compliance with any agreement or condition  contained herein. Any such
extension  or waiver  shall be valid if set forth in an  instrument  in  writing
signed by the party or parties to be bound thereby.


                                       25
<PAGE>


                                   ARTICLE IX

                               General Provisions
                               ------------------

     SECTION 9.01.  Non-Survival of  Representations  Warranties and Agreements.
The  representations,  warranties  and  agreements  in  this  Agreement  and any
certificate  delivered  pursuant hereto by any person shall not terminate at the
Closing Date or upon the termination of this Agreement pursuant to Section 8.01,
as the case may be.

     SECTION 9.02. Notices.  All notices,  requests,  claims,  demands and other
communications  hereunder  shall be in writing  and shall be given (and shall be
deemed to have been duly given  upon  receipt)  by hand  delivery  or  overnight
delivery  service,  return receipt  requested) to the respective  parties at the
following  addresses (or at such other address for a party as shall be specified
in a notice given in accordance with this Section 9.02):

          if to Buyer:

         Brittany Leigh, Inc.
         112 Homeport Drive
         Palm Harbor, Florida 34683
         Attn:_____________________

         with a copy to:


         Ronald P. Teevan
         200 North Garden Avenue, Suite A
         Clearwater, Florida  33755


         if to the Seller:

         Medical Technology Laboratories, Inc.
         12910 Automobile Boulevard
         Clearwater, Florida  33762
         Attn: Todd Siegel


                                       26
<PAGE>

         with a copy to:

         Holland & Knight LLP
         400 North Ashley Drive
         Suite 2300
         Tampa, Florida  33602
         Facsimile: (813) 229-0134
         Attn:  Robert J. Grammig, Esq.

     SECTION 9.03.  Certain  Definitions.  For purposes of this  Agreement,  the
term:

     (a)  "Affiliate"  of a  specified  person  means a person who  directly  or
indirectly through one or more intermediaries  controls, is controlled by, or is
under common control with, such specified person;

     (b) "Beneficial  Owner" with respect to any shares means a person who shall
be deemed to be the beneficial owner of such shares (i) which such person or any
of its affiliates or associates beneficially owns, directly or indirectly;  (ii)
which such  person or any of its  affiliates  or  associates  has,  directly  or
indirectly,  (A) the  right  to  acquire  (whether  such  right  is  exercisable
immediately or subject only to the passage of time),  pursuant to any agreement,
arrangement  or  understanding  or upon the  exercise of  consideration  rights,
exchange  rights,  warrants or options,  or otherwise,  or (B) the right to vote
pursuant to any  agreement,  arrangement  or  understanding;  or (iii) which are
beneficially owned, directly or indirectly,  by any other persons with whom such
person or any of its  affiliates  or  associates  or any  person  with whom such
person or any of its affiliates or associates has any agreement,  arrangement or
understanding for the purpose of acquiring,  holding,  voting, or disposing,  of
any such shares;

     (c)  "Business  Day"  means  any day on which  banks  are not  required  or
authorized to close in the City of Clearwater, Florida;

     (d)  "Control"  (including  the terms  "controlled  by" and  "under  common
control  with") means the  possession,  directly or  indirectly or as trustee or
executor,  of the power to direct or cause the direction of the  management  and
policies of a person,  whether  through the ownership of voting  securities,  as
trustee or executor, by contract or credit arrangement or otherwise;

     (e) "First Union" shall mean First Union National Bank.

     (f)  "Governmental  Authority" means any United States  (federal,  state or
local) or foreign  government,  or  governmental,  regulatory or  administrative
authority, agency or commission;


                                       27
<PAGE>

     (g) "Material  Adverse Effect" means (i) any change or effect that is or is
reasonably  likely  to  be  materially  adverse  to  the  business,  results  of
operations,  or financial  condition of the Buyer or Seller, as the case may be,
(ii) any change or effect  that  otherwise  affects  the ability of the Buyer or
Seller, as the case may be, to consummate the Acquisition, adversely affects the
Buyer's ability to perform its obligations  under the Promissory Note or related
security  documents,  or (iii) any change or effect that  adversely  affects the
ability of Buyer to obtain its Medicare  provider  number or any other  required
state license.

     (h)  "Person"  means  an  individual,  corporation,   partnership,  limited
partnership,  syndicate,  person,  trust,  association  or entity or government,
political subdivision, agency or instrumentality of a Government; and

     (i) "SEC" means the United States Securities and Exchange Commission.

     (j)  "Subsidiary" or  "Subsidiaries"  of any person means any  corporation,
partnership,  joint  venture or other legal entity of which such person  (either
above or through or  together  with any other  subsidiary),  owns,  directly  or
indirectly, more than 50% of the stock or other equity interests, the holders of
which are generally  entitled to vote for the election of the board of directors
or other governing body of such corporation or other legal entity.

     (k) "Tax"  means any  federal,  state,  local,  or  foreign  income,  gross
receipts, franchise, estimated, alternative minimum, add-on minimum, sales, use,
transfer,  registration,  value added,  excise,  natural  resources,  severance,
stamp, occupation,  premium,  windfall profit,  environmental,  customs, duties,
real property,  personal property, capital stock, intangibles,  social security,
unemployment,  disability,  payroll, license, employee, or other tax or levy, of
any kind whatsoever,  including any interest,  penalties, or additions to tax in
respect of the foregoing.

     SECTION  9.04.  Severability.  If any  term  or  other  provision  of  this
Agreement is invalid, illegal or incapable of being enforced by any rule of Law,
or public policy,  all other  conditions and provisions of this Agreement  shall
nevertheless  remain in full force and effect so long as the  economic  or legal
substance of the Acquisition is not affected in any manner materially adverse to
any party. Upon such  determination that any term or other provision is invalid,
illegal or incapable of being  enforced,  the parties hereto shall  negotiate in
good faith to modify this  Agreement so as to effect the original  intent of the
parties as closely as possible in a mutually acceptable manner in order that the
Acquisition  be  consummated  as originally  contemplated  to the fullest extent
possible.


                                       28
<PAGE>

     SECTION 9.05. Entire Agreement;  Assignment. This Agreement constitutes the
entire agreement among the parties with respect to the subject matter hereof and
supersedes all prior agreements and  undertakings,  both written and oral, among
the  parties,  or any of  them,  with  respect  to the  subject  matter  hereof,
excluding  the MA,  which will remain in full force and effect.  This  Agreement
shall not be assigned by operation of law or otherwise.

     SECTION 9.06. Parties in Interest. This Agreement shall be binding upon and
inure solely to the benefit of each party hereto, and nothing in this Agreement,
express or implied,  is intended  to or shall  confer upon any other  person any
right,  benefit  or remedy of any nature  whatsoever  under or by reason of this
Agreement.  Notwithstanding the above, STB shall be a third party beneficiary of
this Agreement.

     SECTION  9.07.  Specific   Performance.   The  parties  hereto  agree  that
irreparable  damage would occur in the event any provision of this Agreement was
not performed in accordance  with the terms hereof and that the parties shall be
entitled to specific  performance of the terms hereof,  in addition to any other
remedy at law or equity.

     SECTION  9.08.  Governing  Law.  This  Agreement  shall be governed by, and
construed pursuant to the laws of Florida.

     SECTION 9.09. Consent to Jurisdiction.

     (a) Any  dispute  between  Buyer  and  Seller  arising  under or in any way
related to this  agreement  shall be resolved in the Circuit  Court for Pinellas
County,  Florida.  Each Party agrees that Pinellas County,  Florida shall be the
exclusive venue for any dispute between the parties.

     (b) Each of the Buyer and the Seller irrevocably consents to the service of
the  summons  and  complaint  and any  other  process  in any  other  action  or
proceeding  relating to the  transactions  contemplated  by this  Agreement,  on
behalf of itself or its  property,  by the  personal  delivery of copies of such
process to such party.  Nothing in this  section  9.09 shall affect the right of
any party to serve legal process in any other manner permitted by law.

     SECTION  9.10.  Headings.   The  descriptive  headings  contained  in  this
Agreement are included for convenience of reference only and shall not affect in
any way the meaning, or interpretation of this Agreement.

     SECTION 9.11.  Counterparts.  This  Agreement may be executed and delivered
(including by facsimile  transmission) in one or more  counterparts,  and by the
different parties hereto in separate  counterparts,  each of which when executed
and delivered  shall be deemed to be an original but all of which taken together
shall constitute one and the same agreement.


                                       29
<PAGE>

     SECTION  9.12.  Waiver of Jury Trial.  Each of Buyer and the Seller  hereby
irrevocably  waives  all  right to trial by jury in any  action,  proceeding  or
counterclaim  (whether based on contract,  tort or otherwise)  arising out of or
relating  to this  Agreement  or the  actions  of  Buyer  or the  Seller  in the
negotiation, administration, performance and enforcement of this Agreement.

     SECTION  9.13.  Covenant  Not to Compete.  The  Seller,  its  officers  and
directors  shall not,  for a period of two years  from the date of the  Closing,
within  the  States  of  Florida,   Alabama,  Georgia,  Texas,  South  Carolina,
Mississippi,  North  Carolina,  Louisiana,  Virginia,  Arkansas,  West Virginia,
Kentucky  and  Tennessee,  directly  or  indirectly,  as an  agent,  consultant,
independent  contractor or in any other capacity:  (a) engage in any business or
activity  which is  competitive  with the  Business  operated by Buyer using the
Purchased  Assets (the  "Business");  (b) render services to a competitor of the
Business; (c) contact,  solicit or attempt to solicit or accept business that is
competitive with the operation of the Business;  or (d) own or operate a medical
laboratory.  Nothing in this Section 9.13 shall prohibit  Seller or its officers
and directors from collecting the accounts receivable of Seller that are part of
the Excluded Assets.

     SECTION 9.14. Construction. If a court of competent jurisdiction determines
the above restrictive covenants are unenforceable,  the parties desire that such
court enforce the above restrictive covenants to the fullest extent permitted by
the laws of Florida.

     SECTION 9.15. Preparation of Agreement. Because each party has participated
fully in the drafting and preparation of this Agreement, the Agreement shall not
be construed more strongly against any party.

     SECTION 9.16.  Representation by Independent  Legal Counsel.  Each party to
this Agreement  hereby  acknowledges and confirms that it has had an opportunity
to retain  independent  legal counsel to independently  advise that party of the
legal  consequences of the Agreement to that party.  Each party to the Agreement
further  acknowledges and confirms that each party to the Agreement received the
strong  recommendation  by all other  parties to the  Agreement  that each party
should retain separate and independent legal counsel to advise each party of the
legal consequences of the Agreement to that party.

     SECTION 9.17 Access. After the Closing,  upon reasonable notice, the Seller
shall have access to and the right to use, the Buyer's computer  systems,  other
information  systems and personnel of the Buyer to assist its efforts to collect
accounts  receivable.  Seller agrees to reimburse  the Buyer for the  reasonable
cost of the time expended by the Buyer's  personnel in taking any of the actions
that are described in this Section 9.17.


                                       30
<PAGE>


     SECTION 9.18  Collections  after the Closing.  Before Buyer obtains its own
Medicare provider number , the Buyer shall deposit all accounts  receivable into
an account  designated  by (and owned by) the Seller on a daily  basis and shall
notify the Seller daily  concerning  such deposits.  The amount of such deposits
will be paid by the  Seller  to the Buyer  within  three  business  days of such
notification.

     IN WITNESS WHEREOF,  the Buyer and the Seller have caused this Agreement to
be executed as of the date first written above.


Medical Technology Laboratories, Inc.

By:_______________________________________
   Name:  Todd Siegel
   Title:  Chairman of the Board of Directors




Brittany Leigh, Inc.

By:_______________________________________

   Name:__________________________________

   Title:__________________________________




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission